Form 8-K - Current report:
SEC Accession No. 0001493152-24-025041
Filing Date
2024-06-25
Accepted
2024-06-25 09:24:12
Documents
13
Period of Report
2024-06-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 29428
  Complete submission text file 0001493152-24-025041.txt   194830

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cqenscom-20240624.xsd EX-101.SCH 3018
3 XBRL LABEL FILE cqenscom-20240624_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cqenscom-20240624_pre.xml EX-101.PRE 22357
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3239
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55470 | Film No.: 241066339
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)